227 related articles for article (PubMed ID: 11342415)
1. The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1.
Li BQ; Wetzel MA; Mikovits JA; Henderson EE; Rogers TJ; Gong W; Le Y; Ruscetti FW; Wang JM
Blood; 2001 May; 97(10):2941-7. PubMed ID: 11342415
[TBL] [Abstract][Full Text] [Related]
2. A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R.
Deng X; Ueda H; Su SB; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM
Blood; 1999 Aug; 94(4):1165-73. PubMed ID: 10438703
[TBL] [Abstract][Full Text] [Related]
3. Desensitization of chemokine receptor CCR5 in dendritic cells at the early stage of differentiation by activation of formyl peptide receptors.
Le Y; Wetzel MA; Shen W; Gong W; Rogers TJ; Henderson EE; Wang JM
Clin Immunol; 2001 Jun; 99(3):365-72. PubMed ID: 11358433
[TBL] [Abstract][Full Text] [Related]
4. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2.
Christophe T; Karlsson A; Dugave C; Rabiet MJ; Boulay F; Dahlgren C
J Biol Chem; 2001 Jun; 276(24):21585-93. PubMed ID: 11285256
[TBL] [Abstract][Full Text] [Related]
5. A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.
Le Y; Shen W; Li B; Gong W; Dunlop NM; Wang JM
Forum (Genova); 1999; 9(4):299-314. PubMed ID: 10611407
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes.
Shen W; Li B; Wetzel MA; Rogers TJ; Henderson EE; Su SB; Gong W; Le Y; Sargeant R; Dimitrov DS; Oppenheim JJ; Wang JM
Blood; 2000 Oct; 96(8):2887-94. PubMed ID: 11023526
[TBL] [Abstract][Full Text] [Related]
7. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM
J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077
[TBL] [Abstract][Full Text] [Related]
8. Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines.
Shen W; Proost P; Li B; Gong W; Le Y; Sargeant R; Murphy PM; Van Damme J; Wang JM
Biochem Biophys Res Commun; 2000 May; 272(1):276-83. PubMed ID: 10872839
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling.
Del Corno M; Liu QH; Schols D; de Clercq E; Gessani S; Freedman BD; Collman RG
Blood; 2001 Nov; 98(10):2909-16. PubMed ID: 11698270
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation.
Liu QH; Williams DA; McManus C; Baribaud F; Doms RW; Schols D; De Clercq E; Kotlikoff MI; Collman RG; Freedman BD
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4832-7. PubMed ID: 10758170
[TBL] [Abstract][Full Text] [Related]
11. A formylpeptide receptor, FPRL1, acts as an efficient coreceptor for primary isolates of human immunodeficiency virus.
Shimizu N; Tanaka A; Mori T; Ohtsuki T; Hoque A; Jinno-Oue A; Apichartpiyakul C; Kusagawa S; Takebe Y; Hoshino H
Retrovirology; 2008 Jun; 5():52. PubMed ID: 18577234
[TBL] [Abstract][Full Text] [Related]
12. Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.
Cashin K; Jakobsen MR; Sterjovski J; Roche M; Ellett A; Flynn JK; Borm K; Gouillou M; Churchill MJ; Gorry PR
Retrovirology; 2013 Sep; 10():98. PubMed ID: 24041034
[TBL] [Abstract][Full Text] [Related]
13. Receptors for chemotactic formyl peptides as pharmacological targets.
Le Y; Yang Y; Cui Y; Yazawa H; Gong W; Qiu C; Wang JM
Int Immunopharmacol; 2002 Jan; 2(1):1-13. PubMed ID: 11789660
[TBL] [Abstract][Full Text] [Related]
14. Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors.
Pontow S; Ratner L
J Virol; 2001 Dec; 75(23):11503-14. PubMed ID: 11689632
[TBL] [Abstract][Full Text] [Related]
15. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.
Glushakova S; Yi Y; Grivel JC; Singh A; Schols D; De Clercq E; Collman RG; Margolis L
J Clin Invest; 1999 Sep; 104(5):R7-R11. PubMed ID: 10487781
[TBL] [Abstract][Full Text] [Related]
16. gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5.
Madani N; Kozak SL; Kavanaugh MP; Kabat D
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8005-10. PubMed ID: 9653130
[TBL] [Abstract][Full Text] [Related]
17. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.
Mörner A; Björndal A; Albert J; Kewalramani VN; Littman DR; Inoue R; Thorstensson R; Fenyö EM; Björling E
J Virol; 1999 Mar; 73(3):2343-9. PubMed ID: 9971817
[TBL] [Abstract][Full Text] [Related]
18. The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.
Cilliers T; Nhlapo J; Coetzer M; Orlovic D; Ketas T; Olson WC; Moore JP; Trkola A; Morris L
J Virol; 2003 Apr; 77(7):4449-56. PubMed ID: 12634405
[TBL] [Abstract][Full Text] [Related]
19. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis.
Yao Q; Compans RW; Chen C
Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813
[TBL] [Abstract][Full Text] [Related]
20. Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1.
Gotoh K; Yoshimori M; Kanbara K; Tamamura H; Kanamoto T; Mochizuki K; Fujii N; Nakashima H
J Infect Chemother; 2001 Mar; 7(1):28-36. PubMed ID: 11406754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
